Cidara Therapeutics, Inc. short interest in 2019
In 2019, Cidara Therapeutics, Inc.'s disclosed short interest ran from 5.97% of shares outstanding on 15 Oct 2019 to 4.03% on 31 Dec 2019, a change of -1.94 percentage points. The year's high was 5.97% on 15 Oct 2019 and its low 4.03% on 31 Dec 2019, averaging 4.87% across 6 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 15.50 days on 15 Oct 2019. Full history: Cidara Therapeutics, Inc..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025
2019 in figures
- Start of year
- 5.97% (15 Oct 2019)
- End of year
- 4.03% (31 Dec 2019)
- Change
- -1.94 pp
- High
- 5.97% (15 Oct 2019)
- Low
- 4.03% (31 Dec 2019)
- Average
- 4.87%
- Highest days to cover
- 15.50 (15 Oct 2019)
- SEC filings marked
- 8
Every report in 2019
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Oct 2019 | 5.97% | 15.50 | 10-K filed, results (8-K), 10-Q filed, results (8-K), 10-Q filed, results (8-K) |
| 31 Oct 2019 | 4.64% | 12.23 | |
| 15 Nov 2019 | 4.93% | 8.81 | 10-Q filed, results (8-K) |
| 29 Nov 2019 | 4.88% | 10.84 | |
| 13 Dec 2019 | 4.79% | 6.74 | |
| 31 Dec 2019 | 4.03% | 5.05 |
See also: Cidara Therapeutics, Inc.'s full history · most shorted US stocks of 2019 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.